- Home
- FTFT vs TLPH Comparison
FTFT vs TLPH Comparison
Compare FTFT & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- TLPH
- Stock Information
- Founded
- FTFT N/A
- TLPH 2005
- Country
- FTFT United States
- TLPH United States
- Employees
- FTFT N/A
- TLPH N/A
- Industry
- FTFT Business Services
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- TLPH Health Care
- Exchange
- FTFT Nasdaq
- TLPH Nasdaq
- Market Cap
- FTFT 11.0M
- TLPH 11.1M
- IPO Year
- FTFT N/A
- TLPH 2011
- Fundamental
- Price
- FTFT $2.21
- TLPH $1.26
- Analyst Decision
- FTFT
- TLPH Strong Buy
- Analyst Count
- FTFT 0
- TLPH 1
- Target Price
- FTFT N/A
- TLPH $6.00
- AVG Volume (30 Days)
- FTFT 487.0K
- TLPH 588.6K
- Earning Date
- FTFT 11-18-2025
- TLPH 11-12-2025
- Dividend Yield
- FTFT N/A
- TLPH N/A
- EPS Growth
- FTFT N/A
- TLPH N/A
- EPS
- FTFT N/A
- TLPH N/A
- Revenue
- FTFT $2,368,206.00
- TLPH $27,000.00
- Revenue This Year
- FTFT N/A
- TLPH N/A
- Revenue Next Year
- FTFT N/A
- TLPH $14,533.26
- P/E Ratio
- FTFT N/A
- TLPH N/A
- Revenue Growth
- FTFT N/A
- TLPH N/A
- 52 Week Low
- FTFT $1.01
- TLPH $0.38
- 52 Week High
- FTFT $5.70
- TLPH $1.20
- Technical
- Relative Strength Index (RSI)
- FTFT 50.57
- TLPH 80.85
- Support Level
- FTFT $2.10
- TLPH $0.86
- Resistance Level
- FTFT $2.28
- TLPH $0.93
- Average True Range (ATR)
- FTFT 0.18
- TLPH 0.09
- MACD
- FTFT -0.01
- TLPH 0.01
- Stochastic Oscillator
- FTFT 65.22
- TLPH 73.00
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.